The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study

被引：2

作者：

Nagi, Mouaddh Abdulmalik ^{[1
,2
]}

Almalki, Ziyad Saeed ^{[3
]}

Thavorncharoensap, Montarat ^{[4
,5
]}

Sangroongruangsri, Sermsiri ^{[4
]}

Turongkaravee, Saowalak ^{[4
]}

Chaikledkaew, Usa ^{[4
,5
]}

Alqahtani, Abdulhadi M. ^{[6
]}

Alsharif, Lamis S. ^{[6
]}

Alsubaihi, Ibrahim A. ^{[7
]}

Alzarea, Abdulaziz, I ^{[8
]}

Alsultan, Mohammed M. ^{[9
]}

机构：

[1] Mahidol Univ, Social Econ & Adm Pharm Program, Dept Pharm, Philosophy Program Social & Adm Pharm, Bangkok, Thailand

[2] Aljanad Univ Sci & Technol, Fac Med Sci, Dept Pharm, Taizi, Yemen

[3] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, POB 173, Riyadh 11942, Saudi Arabia

[4] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10400, Thailand

[5] Mahidol Univ, Mahidol Univ Hlth Technol Assessment MUHTA, Grad Program, Bangkok, Thailand

[6] King Fahad Med City, Res Ctr, Clin Res Dept, Riyadh 12231, Saudi Arabia

[7] Saudi Natl Inst Hlth, Innovat & Knowledge Translat, Riyadh, Saudi Arabia

[8] Al Jouf Univ, Coll Pharm, Dept Clin Pharm, Sakaka, Saudi Arabia

[9] Imam Abdulrahman Bin Faisal Univ, Coll Clin Pharm, Dept Pharm Practice, Dammam, Saudi Arabia

来源：

CLINICOECONOMICS AND OUTCOMES RESEARCH | 2025年 / 17卷

关键词：

body mass index; cost-of-illness; economic burden; obesity; Saudi Arabia; BODY-MASS INDEX; METAANALYSIS; RISK; OVERWEIGHT; DISEASE; ADULTS;

D O I：

10.2147/CEOR.S504462

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Background: The rising prevalence of obesity in the Kingdom of Saudi Arabia (KSA) poses a significant public health challenge. Estimates of the economic cost of obesity are crucial for prioritizing healthcare interventions, guiding policy choices, and justifying budget allocations aimed at reducing obesity prevalence. This study aimed to estimate the cost of obesity in the KSA in 2022. Methods: A prevalence-based cost-of-illness approach was used to determine the cost of obesity. This analysis encompasses 29 diseases, namely obesity and twenty-eight diseases attributable to obesity. Both direct and indirect costs were considered. The annual cost of treatment for each obesity-attributable disease was obtained from the hospital records of one tertiary hospital in the KSA. Data on direct non-medical costs were obtained from the patient survey. The human capital approach was used to estimate the indirect costs of morbidity and mortality. Results: The total economic burden of obesity (2022 values) was estimated at US$116.85 billion from a societal perspective and US $109.67 billion from a healthcare system perspective. From a societal perspective, the total direct medical cost accounted for the largest portion of the total cost (94%). In terms of direct medical costs, the cost of treating diseases attributable to obesity was substantially greater than the cost of treating obesity itself. According to the sensitivity analysis, the total cost ranged from 3.4% of the country's Gross domestic product (GDP) when the unit cost of treatment was reduced by 74% to 9.5% of the country's GDP when the prevalence of obesity and its comorbidities was reduced by 5%. Conclusion: Obesity imposes a substantial economic burden on the healthcare system and society in the KSA. Interventions aimed at promoting healthier lifestyles to reduce the prevalence and incidence of obesity and its comorbidities are highly warranted to alleviate the impact of obesity in the country.

引用

页码：233 / 246

页数：14

共 64 条

[11]

[Anonymous], Global Health Expenditure Database

[12] Setting Population Targets for Measuring Successful Obesity Prevention [J].